Genus plc
From Wikipedia, the free encyclopedia
 | |
| Type | Public |
|---|---|
| Traded as | LSE: GNS |
| Industry | Biotechnology |
| Founded | 1933 |
| Headquarters | Basingstoke, UK |
| Key people |
Bob Lawson, Chairman[1] Karim Bitar, CEO[1] |
| Revenue | £341.8 million (2012)[2] |
| Operating income | £54.2 million (2012)[2] |
| Net income | £39.6 million (2012)[2] |
| Website | www.genusplc.com |
Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
Board of Directors
- Bob Lawson (Chairman).[1]
- Karim Bitar (CEO).[1]
- Stephen Wilson (Group Finance Director).[1]
- Nigel Turner (Senior Non-Executive Director).[1]
- Mike Buzzacott (Non-Executive Director).[1]
- Professor Barry Furr (Non-Executive Director).[1]
- Tom Kilroy (Group General Counsel & Company Secretary).[1]
Operations
The Company has two divisions:
- ABS - products for cattle
- PIC - products for pigs
References
External links
| ||||||||||||||||||||||||||||
| ||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.